Application of lactobacillus rhamnosus in preparation of food or medicine for preventing and/or treating ulcerative colitis
A technology for ulcerative colitis and Lactobacillus is applied in the field of microorganisms to achieve the effects of improving colonic mucosal inflammatory lesions, improving content, and reducing colon histopathological scores
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0061] Preparation of Lactobacillus rhamnosus LRa05 freeze-dried powder:
[0062] Lactobacillus rhamnosus LRa05 was inoculated into the medium according to the inoculum amount accounting for 3% of the total mass of the medium, and cultured at 37°C for 18 hours to obtain a culture solution; the culture solution was centrifuged to obtain a thallus; the thallus was treated with trehalose Lyoprotectant (containing trehalose 100g / L, skimmed milk powder 100g / L) was resuspended (the mass ratio of lyoprotectant to bacteria was 2:1) to obtain a resuspension; the resuspension was vacuum frozen Freeze-drying was carried out to obtain Lactobacillus rhamnosus LRa05 freeze-dried powder, and the number of viable bacteria was detected to be 200 billion CFU / g.
Embodiment 2
[0064] Exploring the effect of Lactobacillus rhamnosus LRa05 on body weight, disease activity index (DAI), colon length and histopathology, myeloperoxidase (MPO) content, oxidative stress marker content, iNOS and COX in mice with ulcerative colitis -2 levels, effects of serum pro-inflammatory cytokines:
[0065] (1) Animal grouping and establishment of ulcerative colitis mouse model:
[0066] The C57BL / 6 mice were randomly divided into 3 groups, 10 in each group, which were normal control group (CTL group), UC model group (UC group) and Lactobacillus rhamnosus LRa05 group (LRa05 group).
[0067] Experimental colitis was induced by oral administration of 3% dextran sodium sulfate DSS (w / v) in drinking water for 7 days. The normal group drank water every day for one week, and the other two groups were given 3% dextran sodium sulfate (w / v) once a day for one week. At the same time, the mice in the Lactobacillus rhamnosus LRa05 group were orally administered the lyophilized powd...
Embodiment 3
[0087] The present embodiment provides a solid drink with the effect of relieving ulcerative colitis, the preparation method is: mixing 0.1 g of Lactobacillus rhamnosus freeze-dried powder obtained in Example 3 with 1.9 g of inulin (inulin) and homogenizing, Made into sachets for brewing. Based on 2.0 grams per bag, this product contains 2 billion live CFU of Lactobacillus rhamnosus LRa05 per bag.
PUM
Property | Measurement | Unit |
---|---|---|
Viable count | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com